Nitrosoglutathione promotes flap survival via suppression of reperfusion injury-induced superoxide and inducible nitric oxide synthase induction

Journal of Trauma - Injury, Infection and Critical Care

Volumn 57, Issue 5, 2004, Pages 1025-1031

  Kuo, Yur Ren ^a   Wang, Feng Sheng ^a   Jeng, Seng Feng ^a   Lutz, Barbara S ^b   Huang, Hui Chen ^a   Yang, Kuender D ^a,c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c Children's Hospital Building   (Taiwan)

Author keywords

Nitric oxide synthase; Nitrosoglutathione; Reperfusion injury; Superoxide

Indexed keywords

3 NITROTYROSINE; ACETYLCYSTEINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; S NITROSOGLUTATHIONE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INDUCTION; GRAFT SURVIVAL; INFERIOR EPIGASTRIC ARTERY; ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZATION; RAT; REPERFUSION; REPERFUSION INJURY; TISSUE FLAP; UPREGULATION;

ANIMALS; ANTIOXIDANTS; FREE RADICAL SCAVENGERS; IMMUNOHISTOCHEMISTRY; MALE; MODELS, ANIMAL; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; RATS; RATS, INBRED LEW; REPERFUSION INJURY; S-NITROSOGLUTATHIONE; SUPEROXIDES; SURGICAL FLAPS; TISSUE SURVIVAL;

EID: 9644279409     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TA.0000100372.92325.32     Document Type: Article

References (36)

1. Kerrigan CL, Stotland MA. Ischemia reperfusion injury: a review. Microsurgery. 1993;14:165-175.
2. Carroll WR, Esclamado RM. Ischemia/reperfusion injury in microvascular surgery. Head Neck. 2000;22:700-713.
3. Collard CD, Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology. 2001;94:1133-1138.
4. Lille ST, Lefler SR, Mowlavi A, et al. Inhibition of the initial wave of NF-kappaB activity in rat muscle reduces ischemia/reperfusion injury. Muscle Nerve. 2001;24:534-541.
5. Valen G, Yan ZQ, Hansson GK. Nuclear factor kappa-B and the heart. J Am Coll Cardiol. 2001;38:307-314.
6. Knight KR, MacPhadyen K, Lepore DA, Kuwata N, Eadie PA, O'Brien BM. Enhancement of ischaemic rabbit skin flap survival with the antioxidant and free-radical scavenger N-acetylcysteine. Clin Sci. 1991;81:31-36.
7. Sehirli AO, Sener G, Satiroglu H, Ayanoglu-Dulger G. Protective effect of N-acetylcysteine on renal ischemia/reperfusion injury in the rat. J Nephrol. 2003;16:75-80.
8. Dhalla NS, Elmoselhi AB, Hata T, Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res. 2000;47:446-456.
9. Moncada S, Palmer RMT, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-142.
10. Oshima H, Inoue H, Aihara M, Tomioka M, Ishida H. Physiological roles of endothelium-derived nitric oxide in the epigastric island flaps of rabbits. Ann Plast Surg. 1997;39:608-614.
11. Gribbe O, Lundeberg T, Samuelson UE, Wiklund NP. Nitric oxide synthase activity and endothelial ultrastructure in ischaemic skin-flaps. Br J Plast Surg. 1997;50:483-490.
12. Spink J, Cohen J, Evans TJ. The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase: activation by nuclear factor-kappaB. J Biol Chem. 1995;270:29541-29547.
13. Nunokawa Y, Oikawa S, Tanaka S. Human inducible nitric oxide synthase gene is transcriptionally regulated by nuclear factor-kappaB dependent mechanism. Biochem Biophy Res Commun. 1996;223:347-352.
14. Molloy J, Martin JF, Baskerville PA, Fraser SC, Markus HS. S-nitrosoglutathione reduces the rate of embolization in humans. Circulation. 1998;98:1372-1375.
15. Kuo YR, Wang FS, Jeng SF, Lutz BS, Huang HC, Yang KD. Nitrosoglutathione improves blood perfusion and flap survival via suppressing iNOS but protecting eNOS expression in the flap vessels after ischemia/reperfusion injury. Surgery. 2004;135:437-446.
16. Kuo YR, Jeng SF, Wang FS, Huang HC, Wei FC, Yang KD. Platelet glycoprotein IIb/IIIa receptor antagonist (Abciximab) inhibited platelet activation and promoted skin flap survival after ischemia/reperfusion injury. J Surg Res. 2002;107:55-59.
17. Wang FS, Wang CJ, Sheen-Chen SM, Kuo YR, Chen RF, Yang KD. Superoxide mediates shock wave induction of ERK-dependent osteogenic transcription factor (CBFAI) and mesenchymal cell differentiation toward osteoprogenitors. J Biol Chem. 2002;277:10931-10937.
18. Abraham E. NF-kappaB activation. Crit Care Med. 2000;28:N100-N104.
19. Manson PN, Anthenelli RM, Im MJ, Bulkley GB, Hoopes JE. The role of oxygen free radicals in ischemic tissue injury in island skin flap. Ann Surg. 1983;198:87-90.
20. Picard-Ami LA Jr, Mckay A, Kerrigan CL. Effect of allopurinol on the survival of experimental pig flaps. Plast Reconstr Surg. 1992;89:1098-1103.
21. Sagi A, Ferder M, Levens D, Strauch B. Improved survival of island flaps after prolonged ischemia by perfusion with superoxide dismutase. Plast Reconstr Surg. 1986;77:639-644.
22. Walker PM, Lindsay TF, Labbe R, Mickle DA, Romaschin AD. Salvage of skeletal muscle with free radical scavengers. J Vasc Surg. 1987;5:68-75.
23. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev. 2001;53:135-159.
24. Heller AR, Groth G, Heller SC, et al. N-acetylcysteine reduces respiratory burst but augments neutrophil phagocytosis in intensive care unit patients. Crit Care Med. 2001;29:272-276.
25. Ortolani O, Conti A, De Gaudio AR, Moraldi E, Cantini Q, Novelli G. The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock. Am J Respir Crit Care Med. 2000;161:1907-1911.
26. Taut FJ, Schmidt H, Zapletal CM. N-acetylcysteine induces shedding of selectins from liver and intestine during orthotopic liver transplantation. Clin Exp Immunol. 2001;124:337-341.
27. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
28. Wang WZ, Anderson G, Fleming JT, et al. Lack of nitric oxide contributes to vasospasm during ischemia/reperfusion injury. Plast Reconstr Surg. 1997;99:1099-1108.
29. Cordeiro PG, Mastorakos DP, Hu QY, Kirscher RE. The protective effect of L-arginine on ischemia-reperfusion injury in rat skin flaps. Plast Reconstr Surg. 1997;100:1227-1233.
30. Radomski MW, Moncada S. The biological and pharmacological role of nitric oxide in platelet function. Adv Exp Med Biol. 1993;344:251-264.
31. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA. 1991;88:4651-4655.
32. Cooke CL, Davidge ST. Peroxynitrite increases iNOS through NF-κB and decreases prostacyclin synthase in endothelial cells. Am J Physiol. 2002;282:C395-C402.
33. Singh RJ, Hogg N, Joseph J, Kalyanaraman B. Mechanism of nitric oxide release from S-nitrosothiols. J Biol Chem. 1996;271:18596-18603.
34. Huk I, Nanobashvili J, Neumayer C, et al. L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation. 1997;96:667-675.
35. Um SC, Suzuki S, Toyokuni S, Uchida K, Hiai H, Nishimura Y. Formation of 4-hydroxy-2-nonenal-modified proteins and 3-nitro-L-tyrosine in rat island skin flaps during and after ischemia. Ann Plast Surg. 1999;42:293-298.
36. Hayashi Y, Sawa Y, Ohtake S, Fukuyama N, Nakazawa H, Matsuda H. Peroxynitrite formation from human myocardium after ischemia-reperfusion during open heart operation. Ann Thorac Surg. 2001;72:571-576.